Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael S. Wyzga currently holds 25,050 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Wyzga has been a net seller of GENZ stock. They have purchased $55.5K and sold $6.6M worth of shares.
Michael S. Wyzga's most recent insider trade was on Jun 17, 2024, when they sold 25,050 shares at $3.99 per share.
Michael S. Wyzga serves as Executive at GENZYME CORP (GENZ). They have executed 37 insider transactions totaling $6.7M over their tenure at the company.
Michael S. Wyzga holds the position of Executive at GENZYME CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Michael S. Wyzga has shown a selling trading pattern, with $55.5K in total purchases and $6.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael S. Wyzga was on Feb 26, 2021, when they sold $2.5M worth of EXAS shares. This transaction involved 19,021 shares at $130.11 per share.
Michael S. Wyzga currently owns 25,050 shares of GENZYME CORP (GENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael S. Wyzga's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael S. Wyzga has 37 Form 4 filings on record as an insider at GENZYME CORP.
Set alerts for Michael S. Wyzga and 40,000+ other insiders.